Naoero vs Turkmenistan: New cases tested for RR-/MDR-TB
Naoero
100.0%
in 2023
Turkmenistan
100.0%
in 2022
Naoero rank
1st
Turkmenistan rank
1st
New cases tested for RR-/MDR-TB over time
- Naoero
- Turkmenistan
How they compare
Naoero currently reports 100.0% against 100.0% in Turkmenistan, a difference of 0.0%.
Across all 6 years both countries report, Turkmenistan has been ahead every year.
Naoero ranks 1st and Turkmenistan ranks 1st of 192 countries.
Turkmenistan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Naoero | Turkmenistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 12.0% | 12.0% | Turkmenistan |
| 2010s | 0.0% | 64.0% | 64.0% | Turkmenistan |
| 2020s | 66.7% | 100.0% | 33.3% | Turkmenistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Naoero or Turkmenistan?
- Naoero, at 100.0% against 100.0% in Turkmenistan as of 2023.
- What is the difference in new cases tested for rr-/mdr-tb between Naoero and Turkmenistan?
- 0.0%, with Naoero ahead.
- How many years of comparable data are there for Naoero and Turkmenistan?
- 6 years are reported by both, from 2009 to 2022.
- How do Naoero and Turkmenistan rank globally for new cases tested for rr-/mdr-tb?
- Naoero ranks 1st and Turkmenistan ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.